Allergy Therapeutics plc (AIM: AGY)

Allergy Therapeutics Balance Sheet

Financials in millions GBP. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	12.92	12.92	14.85	20.52	40.27	36.96
Cash & Short-Term Investments	12.92	12.92	14.85	20.52	40.27	36.96
Cash Growth	-13.00%	-13.00%	-27.64%	-49.06%	8.96%	34.70%
Accounts Receivable	2.86	2.86	2.37	2.69	2.96	3.49
Other Receivables	3.35	3.35	2.69	3.21	1.66	2.16
Receivables	6.21	6.21	5.06	5.91	4.62	5.65
Inventory	12.74	12.74	11.59	11.41	10.84	10.13
Prepaid Expenses	1.62	1.62	2.03	4.56	1.6	2.42
Other Current Assets	-	-	-	-	0.53	-
Total Current Assets	33.48	33.48	33.53	42.39	57.86	55.17
Property, Plant & Equipment	23.75	23.75	23.24	20.19	19.72	20.42
Goodwill	3.32	3.32	3.35	3.35	3.34	3.47
Other Intangible Assets	1.37	1.37	1.79	1.69	1.41	1.27
Other Long-Term Assets	2.91	2.91	4.87	5.33	5.76	5.9
Total Assets	64.83	64.83	66.77	72.95	88.09	86.23
Accounts Payable	15.94	15.94	4.09	4.28	2.9	2.22
Accrued Expenses	-	-	12.49	11.34	13.55	12.86
Current Portion of Long-Term Debt	0.6	0.6	0.65	0.95	0.96	0.83
Current Portion of Leases	1.52	1.52	1.16	1.32	0.79	1.44
Other Current Liabilities	2.49	2.49	0.18	0.16	0.03	0.89
Total Current Liabilities	20.55	20.55	18.57	18.05	18.23	18.23
Long-Term Debt	22.5	22.5	26.44	1.5	2.45	2.93
Long-Term Leases	6.37	6.37	7.75	6.76	6.97	6.99
Long-Term Deferred Tax Liabilities	0.38	0.38	0.45	0.41	0.41	0.47
Other Long-Term Liabilities	2.71	2.71	3.58	0.14	0.21	0.3
Total Liabilities	61.12	61.12	64.7	35.18	39.55	42.44
Common Stock	4.77	4.77	0.68	0.64	0.64	0.64
Additional Paid-In Capital	154.64	154.64	119.03	112.58	112.58	112.58
Retained Earnings	-198.93	-198.93	-161.87	-118.54	-107.4	-112.96
Comprehensive Income & Other	43.23	43.23	44.23	43.09	42.72	43.53
Shareholders' Equity	3.71	3.71	2.07	37.77	48.54	43.78
Total Liabilities & Equity	64.83	64.83	66.77	72.95	88.09	86.23
Total Debt	30.99	30.99	35.99	10.53	11.17	12.18
Net Cash (Debt)	-18.07	-18.07	-21.14	9.99	29.1	24.78
Net Cash Growth	-	-	-	-65.69%	17.42%	-0.88%
Net Cash Per Share	-0.00	-0.00	-0.03	0.02	0.04	0.04
Filing Date Shares Outstanding	4,776	4,776	679.1	644.1	641.77	637.29
Total Common Shares Outstanding	4,776	4,776	679.1	644.1	641.77	637.29
Working Capital	12.94	12.94	14.96	24.34	39.63	36.94
Book Value Per Share	0.00	0.00	0.00	0.06	0.08	0.07
Tangible Book Value	-0.98	-0.98	-3.07	32.73	43.78	39.05
Tangible Book Value Per Share	-0.00	-0.00	-0.00	0.05	0.07	0.06
Land	-	-	3.05	3.08	3.09	11.87
Machinery	-	-	33.68	29.66	27.35	26.97

Source: S&P Capital IQ. Standard template. Financial Sources.